Why is Neuronetics stock tumbling today?

Neuronetics Inc stock experienced a significant 11.4% drop in pre-open trading today due to the company's pricing of an underwritten public offering of 18.75 million shares at $1.60 per share. This offering, led by William Blair with BTIG and Canaccord Genuity as co-bookrunners, aimed to generate around $30 million in gross proceeds before expenses. The discounted price represented a substantial reduction from the stock's recent trading range.

The capital raise is closely linked to Neuronetics' efforts to address a "going concern" risk, a concern highlighted in recent SEC filings. On November 5, the company entered into a sixth amendment to its credit agreement with Perceptive Credit Holdings IV, LP, which would adjust revenue covenants contingent on a prepayment of at least $15 million on an outstanding term loan by November 30, 2026. A portion of the offering proceeds is set aside to meet this repayment requirement.

Additionally, the Securities and Exchange Commission (SEC) was notified on November 11 via a Form 144, indicating an anticipated sale of securities by an insider or affiliate. Despite Neuronetics reporting positive operational momentum in its third quarter, with a 12.5% year-over-year revenue increase and a shift to positive adjusted EBITDA, the company's financial structure concerns overshadowed these gains in today's market.

The broader market, with the S&P 500 and Nasdaq both on an upward trend, provided little solace for the stock's decline. The steep discount on the share offering, combined with the urgency of the November 30 deadline to fulfill credit amendment conditions and the insider sale notice, created a confluence of negative factors. These elements collectively drove Neuronetics' stock price down sharply in pre-market trading, despite positive performance among peers and the broader market.